These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8177746)

  • 41. Vascular endothelial growth factor antisense oligodeoxynucleotides with lipiodol in arterial embolization of liver cancer in rats.
    Wu HP; Feng GS; Liang HM; Zheng CS; Li X
    World J Gastroenterol; 2004 Mar; 10(6):813-8. PubMed ID: 15040023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is antisense an appropriate nomenclature or design for oligodeoxynucleotides aimed at the inhibition of HIV-1 replication?
    Lavigne C; Yelle J; Sauve G; Thierry AR
    AAPS PharmSci; 2002; 4(2):E9. PubMed ID: 12102618
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Folic acid-polylysine carrier improves efficacy of c-myc antisense oligodeoxynucleotides on human melanoma (M14) cells.
    Ginobbi P; Geiser TA; Ombres D; Citro G
    Anticancer Res; 1997; 17(1A):29-35. PubMed ID: 9066627
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inhibition of CD4 expression by antisense oligonucleotides in PMA-treated lymphocytes.
    Rabanal M; Franch A; Noé V; Ciudad CJ; Castell M; Castellote C
    Antisense Nucleic Acid Drug Dev; 2002 Dec; 12(6):399-410. PubMed ID: 12568314
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electroporation enhances c-myc antisense oligodeoxynucleotide efficacy.
    Bergan R; Connell Y; Fahmy B; Neckers L
    Nucleic Acids Res; 1993 Jul; 21(15):3567-73. PubMed ID: 8346033
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delivery of oligodeoxynucleotides into human saphenous veins and the adjunct effect of ultrasound and microbubbles.
    Kodama T; Tan PH; Offiah I; Partridge T; Cook T; George AJ; Blomley MJ
    Ultrasound Med Biol; 2005 Dec; 31(12):1683-91. PubMed ID: 16344130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2'-O-methyl-modified phosphorothioate antisense oligonucleotides have reduced non-specific effects in vitro.
    Yoo BH; Bochkareva E; Bochkarev A; Mou TC; Gray DM
    Nucleic Acids Res; 2004; 32(6):2008-16. PubMed ID: 15064360
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of phosphorothioate oligodeoxynucleotides on various organs in vivo.
    Nieborowska-Skórska M; Białek AP; Nicolaides NC; Iozzo RV; Kawalec M; Calabretta B; Kawiak J; Marlicz K; Skórski T
    Folia Histochem Cytobiol; 1996; 34(2):69-73. PubMed ID: 8875213
    [TBL] [Abstract][Full Text] [Related]  

  • 49. VEGF-A signaling through Flk-1 is a critical facilitator of early embryonic lung epithelial to endothelial crosstalk and branching morphogenesis.
    Del Moral PM; Sala FG; Tefft D; Shi W; Keshet E; Bellusci S; Warburton D
    Dev Biol; 2006 Feb; 290(1):177-88. PubMed ID: 16375885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Timeless in lung morphogenesis.
    Xiao J; Li C; Zhu NL; Borok Z; Minoo P
    Dev Dyn; 2003 Sep; 228(1):82-94. PubMed ID: 12950082
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Efficient cationic lipid-mediated delivery of antisense oligonucleotides into eukaryotic cells: down-regulation of the corticotropin-releasing factor receptor.
    Shi F; Nomden A; Oberle V; Engberts JB; Hoekstra D
    Nucleic Acids Res; 2001 May; 29(10):2079-87. PubMed ID: 11353077
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-myc antisense oligodeoxynucleotides enhance the efficacy of cisplatin in melanoma chemotherapy in vitro and in nude mice.
    Citro G; D'Agnano I; Leonetti C; Perini R; Bucci B; Zon G; Calabretta B; Zupi G
    Cancer Res; 1998 Jan; 58(2):283-9. PubMed ID: 9443406
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.
    Caselmann WH; Eisenhardt S; Alt M
    Intervirology; 1997; 40(5-6):394-9. PubMed ID: 9675643
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antisense gene inhibition by C-5-substituted deoxyuridine-containing oligodeoxynucleotides.
    Gutierrez AJ; Matteucci MD; Grant D; Matsumura S; Wagner RW; Froehler BC
    Biochemistry; 1997 Jan; 36(4):743-8. PubMed ID: 9020771
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Patterning parameters associated with the branching of the ureteric bud regulated by epithelial-mesenchymal interactions.
    Lin Y; Zhang S; Tuukkanen J; Peltoketo H; Pihlajaniemi T; Vainio S
    Int J Dev Biol; 2003 Feb; 47(1):3-13. PubMed ID: 12653247
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Abrogation of Smad3 and Smad2 or of Smad4 gene expression positively regulates murine embryonic lung branching morphogenesis in culture.
    Zhao J; Lee M; Smith S; Warburton D
    Dev Biol; 1998 Feb; 194(2):182-95. PubMed ID: 9501027
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice.
    Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S
    Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Spatiotemporal patterns of sortilin and SorCS2 localization during organ development.
    Boggild S; Molgaard S; Glerup S; Nyengaard JR
    BMC Cell Biol; 2016 Mar; 17():8. PubMed ID: 26964886
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An antisense oligonucleotide carrier based on amino silica nanoparticles for antisense inhibition of cancer cells.
    Peng J; He X; Wang K; Tan W; Li H; Xing X; Wang Y
    Nanomedicine; 2006 Jun; 2(2):113-20. PubMed ID: 17292123
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hoechst-Modification on Oligodeoxynucleotides for Efficient Transport to the Cell Nucleus and Gene Regulation.
    Makanai H; Nishihara T; Nishikawa M; Tanabe K
    Chembiochem; 2024 Feb; 25(3):e202300645. PubMed ID: 37984902
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.